Senju Pharmaceutical: Estrogen tablets/Estrogen progesterone tablets composite packaging drug registration application has been accepted.

Shenju Pharmaceutical announced that the company recently received a notification of acceptance of the registration of domestically produced drugs for estradiol tablets/estradiol dienogest tablets composite packaging issued by the National Medical Products Administration. The product name is estradiol tablets/estradiol dienogest tablets composite packaging, the dosage form is tablets, and the specifications include estradiol tablets containing 1mg of estradiol and estradiol dienogest tablets containing 1mg of estradiol and 10mg of dienogest, as well as estradiol tablets containing 2mg of estradiol and estradiol dienogest tablets containing 2mg of estradiol and 10mg of dienogest. The application is for the registration and market approval of domestically produced drugs, with acceptance numbers CYHS2504314 and CYHS2504315 respectively.